Key Finding
Participants in an integrative transdisciplinary chronic pain program showed statistically significant improvements across all patient-reported outcomes alongside a 65% reduction in emergency room visits and an 18% decrease in total cost of care in the year following the program.
Living with chronic pain can feel overwhelming, affecting not just your body but your sleep, mood, energy, and ability to enjoy daily life. A new study from Vermont offers encouraging news for people seeking relief beyond conventional treatments.
Researchers evaluated a program called PATH (Partners Aligned in Transformative Healing), run through the University of Vermont Medical Center's Comprehensive Pain Program. PATH is an integrative, team-based program that combines multiple healing approaches — including integrative therapies — delivered over several weeks. The goal was to see whether this kind of whole-person care could genuinely help people with high-impact chronic pain.
The results were promising. Of the 170 people who enrolled between 2019 and 2022, 151 completed the program. Participants reported meaningful improvements across a wide range of measures. Pain interference in daily life decreased significantly. So did fatigue, sleep disturbance, anxiety, and depression. Physical function and the ability to participate in social activities both improved.
Perhaps most striking were the real-world cost and healthcare use outcomes. Emergency room visits dropped by 65% overall — and by 67% for pain-related visits specifically — in the year following the program. The total monthly cost of care fell by 18%, or about $462 per person per month.
What this means for you: if you're living with chronic pain, a comprehensive integrative approach that treats the whole person — not just the pain itself — may help you feel better and rely less on emergency care. Acupuncture is increasingly included in programs like PATH because of its role in reducing pain, stress, and inflammation without significant side effects.
This study adds to a growing body of evidence supporting integrative pain care. To explore whether this approach is right for you, consider consulting a licensed acupuncturist with experience in chronic pain management.
This prospective feasibility study evaluated the PATH (Partners Aligned in Transformative Healing) transdisciplinary integrative pain program at the University of Vermont Medical Center (June 2019–August 2022). Of 170 enrolled patients with high-impact chronic pain, 151 (88.8%) completed the multi-week program; 121 provided complete PRO data. The cohort was predominantly White (98%), female (76%), mean age 49.8 years. All PROs reached statistical significance (paired T-test, P<0.05). PROMIS-29 domains showed significant improvements in pain interference, fatigue, sleep disturbance, anxiety, depression, physical function, and social participation. PEG subscales similarly improved. Insurance claims analysis (12-month pre/post) demonstrated an 18% reduction in Per Member Per Month total cost of care (−$462 PMPM). ER utilization fell 65% for all diagnoses and 67% for pain-specific diagnoses. Clinical takeaway: A bundled-payment integrative model incorporating empirically validated assessments demonstrates both clinical and economic feasibility for chronic pain populations, warranting a multi-site RCT.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture was recognized as a complementary modality within multimodal cancer pain management, but current evidence remains preliminary and heterogeneous, necessitating further high-quality trials before definitive clinical recommendations can be established.
📌 A single acupuncture or integrative medicine encounter produced clinically meaningful reductions in pain (−2.50), stress (−3.22), and anxiety (−3.05) on a numeric rating scale among outpatients presenting with moderate-to-severe symptoms.
📌 Acupuncture therapy was successfully integrated into a low-resource global health mission in Guatemala, where 100% of the 11 patients presented with pain and the majority reported co-occurring depression and insomnia, demonstrating feasibility and patient receptivity despite near-universal unfamiliarity with the treatment.